期刊文献+

肾周脂肪面积是胃癌术后短期并发症的影响因素 被引量:1

Perirenal fat surface area is an important factor of short-term complications of gastric cancer
下载PDF
导出
摘要 目的探讨肾周脂肪面积用于评估腹型肥胖的价值及对经腹胃癌根治术术后短期并发症的影响。方法回顾性分析接受胃癌外科治疗的114例患者临床资料,根据Clavien系统分为有并发症组和无并发症组进行比较分析。结果总体的体质指数(BMI)为(21.1±3.2)kg/m^2,总体的肾周脂肪面积为(26.0±8.2)cm^2,肾周脂肪面积与腹腔脂肪面积有较高的相关性(r=0.928,P<0.001)。年龄、肾周脂肪面积在两组间的差异有统计学意义(P<0.05),而性别、手术方式、TNM分期两组间差异无统计学意义。多因素分析显示年龄、BMI、肾周脂肪面积均为独立危险因素(P<0.05)。结论肾周脂肪面积是反映腹腔内脂肪情况的较好指标,在经腹胃癌根治术术后短期并发症的预期上可作为独立风险因素,预测价值高于BMI。 Objective To investigate the perirenal fat surface area in evaluating assess the abdominal obesity and its influence on complications after radical gastrectomy. Methods The clinical data from 114 patients who received surgical treatment of gastric cancer were analyzed retrospectively. The surgical data and postoperative conditions in- cluding short-term outcome were reviewed and all the patients were divided into two groups according to the Clavien system and compared between the two groups. Results The mean BMI index was (21.1 ± 3.2) kg/m2 and the mean perirenal fat surface area was (26.0 ± 8.2) cm2 in the two groups. Perirenal fat surface was strong correlated with visceral fat ( r = 0. 928, P 〈 0. 001 ). There were statistically significant differences between the two groups in- terms of age, BMI and perirenal fat area ( P 〈 0. 05 ) , whereas gender, surgical approach, TNM stage were not. Multivariate analysis confirmed age, BMI, perirenal fat area were independent risk factors for postoperative compli- cations (P 〈 0.05 ). Conclusion Perirenal fat surface area is a good indicator of visceral fat volume. What' s more, it is an independent risk factor for the forecast of short-term complications in patients with gastric carcinoma underwent radical resection which showed higher predictive value than BMI.
出处 《安徽医科大学学报》 CAS 北大核心 2016年第5期717-720,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省科技攻关项目(编号:1301043054)
关键词 胃癌 肥胖 肾周脂肪面积 并发症 stomach neoplasms obesity perirenal fat postoperative complications
  • 相关文献

参考文献9

  • 1Tsujinaka T, Sasako M, Yamamoto S, et al. Influence of over- weight on surgical complications for gastric cancer: results from a randomized control trial comparing I)2 and extended para-aortic D5 lymphadenectomy (JCOG9501) [ J]. Ann Surg Oncol, 2007, 14 (2) :355 -61.
  • 2Jung M, Volont6 F, Buchs N C, et al. Perirenal fat surface area as a risk factor for morbidity after elective colorectal surgery [ J ]. Dis Colon Rectum, 2014, 57(2) :201 -9.
  • 3Dindo D, Demartines N, Clavien P A. Classification of surgical complications : a new proposal with evaluation in a cohort of 6 336patients and results of a survey [ J ]. Ann Surg, 2004, 240 ( 2 ) : 205 - 13.
  • 4胡春婷,田刚.多层螺旋CT及后处理技术评价腹部及血管周围脂肪[J].中国组织工程研究,2012,16(39):7292-7297. 被引量:3
  • 5Makino H, Kunisaki C, Akiyama H, et al. Effect of obesity on in- traoperative bleeding volume in open gastrectomy with D2 lymph- node dissection for gastric cancer[ J]. Patient Saf Surg, 2008, 2 (1):1 -6.
  • 6Tokunaga M, Hiki N, Fukunaga T, et al. Effect of individual fat ar- eas on early surgical outcomes after open gastrectomy for gastric cancer [ J ]. Br J Surg,2009,96 ( 5 ) :496 - 500.
  • 7Tanaka K, Miyashiro I,Yano M, et al. Accumulation of excess vis- ceral fat is a risk factor for pancreatic fistula formation after total gastrectomy [ J]. Ann Surg Oncol, 2009, 16 (6) :1520 -5.
  • 8张丽萍,梅俏,许建明,张爽.消化道肿瘤切除术后患者营养风险评估及血浆ghrelin水平检测的临床研究[J].安徽医科大学学报,2012,47(3):340-342. 被引量:6
  • 9Morris K, Tuorto S, Gonen M,et al. Simple measurement of intra- abdominal fat for abdominal surgery outcome prediction [ J ]. Arch Surg,2010,145 (11) :1069 -73.

二级参考文献41

  • 1Jui-Hsiang Tang,Yung-Kuan Tsou,Hao-Tsai Cheng,Mu-Hsien Lee,Ching-Song Lee,Nai-Jen Liu.Double balloon endoscopy increases the ERCP success rate in patients with a history of Billroth Ⅱ gastrectomy[J].World Journal of Gastroenterology,2010,16(36):4594-4598. 被引量:6
  • 2Sung J,Bochicchio G V,Joshi M,et al.Admission serum albumin is predicitve of outcome in critically ill trauma patients[J].Am Surg,2004,70(12):1099-102.
  • 3Kojima M,Kangawa K.Drug insight:The functions of ghrelin and its potential as a multitherapeutic hormone[J].Nat Clin Pract Endocrinol Metab,2006,2(10):80-8.
  • 4Tritos N A,Kokkotou E G.The physiology and potential clinical applications of ghrelin,a novel peptide hormone[J].Mayo Clin Proc,2006,81(5):653-60.
  • 5Rapp-Kesek D,Stable E,Karlsson T T,et al.Body mass index and albumin in the preoperative evaluation of cardiac surgery patients[J].Clin Nutr,2004,23(6):1338-404.
  • 6Lochs H,Allison S P,MeieR R,et al.Introductory to the ESPEN Guidelines on Enteral Nutrition:Terminology,definitions and general topics[J].Clin Nutr,2006,25(2):180-6.
  • 7Green S M,Watson R.Nutritional screening and assessment tools foR use by nurses:literature review[J].J Adv Nurs,2005,50(1):69-83.
  • 8Koundrup J,Allison S P,Elia M,et al.ESPEN guidelines foR nutrition screening 2002[J].Clin Nutr,2003,22(4):415-21.
  • 9中国医学会.临床诊疗指南-肠内肠外营养学分册[M].北京:人民卫生出版社,2006:15-6.
  • 10Abu-Abid S,Szold A,Klaussner J. Obesity and cancer[J].MED,2002.73-86.

共引文献7

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部